Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2732818
Title:
ANTAGONISTE DES RECEPTEURS DE L'ENDOTHELINE ET DE L'ANGIOTENSINE II A BASE DE BIPHENYLSULFONAMIDE POUR TRAITER LA GLOMERULOSCLEROSE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
141554592
WO application number:
Type:
European patent granted for BE
Status:
Open
Publication number:
2732818
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
29/03/2010
Grant date:
03/05/2017
EP publication date:
21/05/2014
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
03/05/2017
EP B1 publication date:
03/05/2017
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
29/03/2030
Applicant
Name:
Ligand Pharmaceuticals Inc.
Legal Form:
From:
26/10/2017
Address:
3911 Sorrento Valley Boulevard
Suite 110, San Diego, CA 92121, United States (US)
To:
Agent
Name:
KIRKPATRICK
Legal Form:
From:
19/07/2017
Address:
Avenue Wolfers 32, 1310, LA HULPE, Brabant wallon, Belgium (BE)
To:
Inventor
1
Name:
Zhang, Jinkun
Legal Form:
Address:
San Diego, CA California 92128, United States (US)
2
Name:
Dziewanowska, Zofia E
Legal Form:
Address:
La Jolla, CA California 92037, United States (US)
3
Name:
Belder, Rene
Legal Form:
Address:
Hopewell, NJ New Jersey 08525, United States (US)
4
Name:
Henderson, Ian
Legal Form:
Address:
San Diego, CA California 92122, United States (US)